Recruiting
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis - IM101-679
Updated: 2 April, 2018 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Gender(s)
Age Range
Location(s)
Recruiting
Treatment Options
Inclusion Criteria: - Participants recently (within the last 24 months before enrollment) diagnosed with established moderate to severe active RA - Participants naïve of abatacept and who, at their physician's discretion, are initiated with abatacept according the German label/SmPC (Summary of product characteristics) Exclusion Criteria: - Participants who are currently included in any interventional clinical trial in RA Other protocol defined inclusion/exclusion criteria could apply
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
